Company News
Symbiotec Subsidiary Knovea Signs US DCV Agreement
Symbiotec's subsidiary Knovea Pharmaceutical enters exclusive US commercialization agreement for Dual Chamber Vial products with global pharma company.
Agreement covers two DCV-based injectable produc
